LTI-03 reduced tissue scarring-promoting protein levels in the first group of IPF patients participating in a Phase 1b trial, ...

New research led by Unity Health Toronto that examines how fibroblast cells in the body are activated to cause fibrosis and ...

The results of the study ‘TANGO1 inhibitors reduce collagen secretion and limit tissue scarring’ have been published in Nature Communications. The extracellular matrix (ECM) is a substance that fills ...

Researchers show that the possible cause of local bone erosion in cholesteatomas are fibroblasts from the bone that express a ...

Stimulates Fibroblasts to Reduce Fine Lines and Wrinkles: By activating fibroblast cells, this treatment initiates the ...

FibroBiologics is developing CYMS101, a fibroblast cell therapy made of human skin fibroblasts that's shown promise in preclinical studies.

Low-dose LTI-03 (2.5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both pathological basal-like ...